Draper Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,999
Closed -$371K 26
2024
Q1
$371K Sell
6,999
-22
-0.3% -$1.12K 0.32% 20
2023
Q4
$360K Buy
7,021
+1,001
+17% +$52.5K 0.34% 18
2023
Q3
$349K Buy
+6,020
New +$369K 0.37% 20
2022
Q3
Sell
-12,809
Closed -$986K 25
2022
Q2
$986K Buy
12,809
+501
+4% +$38.2K 1.16% 13
2022
Q1
$899K Buy
+12,308
New +$826K 0.74% 15

Other funds holding BMY

Draper Asset Management's BMY Position: Q2 2024 in Review

Draper Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 6,999 shares — an estimated $371K sold.

Draper Asset Management first reported a position in BMY in Q1 2022 and held it in 5 quarters. The position peaked at $986K in Q2 2022. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Draper Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Draper Asset Management sold 6,999 Bristol-Myers Squibb shares in Q2 2024, an estimated $371K.
  • Draper Asset Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 5 quarters.
  • Draper Asset Management's Bristol-Myers Squibb position peaked at $986K in Q2 2022.
  • 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Draper Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.